Louisiana 2010 Regular Session

Louisiana House Bill HB1286

Introduced
4/14/10  
Refer
4/15/10  
Report Pass
5/3/10  
Engrossed
5/12/10  
Refer
5/13/10  
Report Pass
6/2/10  
Enrolled
6/11/10  
Chaptered
6/21/10  

Caption

Provides relative to the organization and budget of the Patient's Compensation Fund and the Patient's Compensation Fund Oversight Board

Impact

The implementation of HB 1286 will specifically affect the management structure of the Patient's Compensation Fund, as it delineates how the fund operates independently of state budgetary constraints. This change is anticipated to enable the fund to allocate resources more effectively in supporting medical malpractice claimants. Furthermore, it ensures that funds generated through voluntary contributions from healthcare providers are managed separately from public funds, providing a measure of protection against potential governmental budget cuts.

Summary

House Bill 1286 seeks to amend the organization and budgeting procedures of the Patient's Compensation Fund and its Oversight Board in Louisiana. The bill stipulates that these entities shall not be considered as budget units of the state and establishes protocols for how the fund's resources should be deposited and invested. The intent of the bill is to provide clarity in the governance of the compensation fund, which is crucial for addressing medical malpractice claims within the state. By consolidating its financial management and oversight under clearer executive regulations, this bill aims to ensure more efficient operations of the Patient's Compensation Fund.

Sentiment

The sentiment around HB 1286 appears to be largely supportive as it aims to enhance the efficiency and clarity of how the Patient's Compensation Fund operates. Stakeholders in the healthcare sector have expressed optimism that the modifications will lead to better management of resources and quicker disbursement of compensation where necessary. However, there are discernible concerns regarding the oversight mechanisms and whether the new structure will adequately safeguard against potential misuse or mismanagement of the fund’s resources.

Contention

One of the notable points of contention regarding the bill revolves around the autonomy it grants to the Patient's Compensation Fund Oversight Board. Critics have raised concerns that minimizing state oversight could lead to a lack of accountability in how funds are handled. Additionally, debates have arisen regarding what constitutes 'private funds' versus 'public funds' and how these distinctions will affect the transparency of operations. Moving forward, the bill's ability to maintain checks and balances while providing operational flexibility will be pivotal in addressing these concerns.

Companion Bills

No companion bills found.

Similar Bills

TX HB2157

Relating to a requirement that a hospital allow a patient to designate a caregiver to receive aftercare instruction regarding the patient.

NJ A2331

Prohibits certain steering and marketing practices involving dispensing of prescription drugs and drug samples.

NJ A2587

Prohibits certain steering and marketing practices involving dispensing of prescription drugs and drug samples.

NJ S1158

Prohibits certain steering and marketing practices involving dispensing of prescription drugs and drug samples.

NJ S958

Establishes right of hospital patients to be accompanied by patient advocate.

TX HB1901

Relating to the disclosure of certain mental health records of deceased state hospital patients.

TX HB2425

Relating to a requirement that a hospital allow a patient to designate a caregiver to receive aftercare instruction regarding the patient.

TX SB1417

Relating to a requirement that a hospital allow a patient to designate a caregiver to receive aftercare instruction regarding the patient.